Skip to main content
HCPCS J7639 · Level II · Part B drug

J7639: dornase alfa (Pulmozyme), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J7639

Billing unit
1 MG
Dornase alfa non-comp unit
ASP payment limit
$56.806
October 2026; +0.1% vs July 2026
Practitioner MUE
3
MAI 3
OPPS status
SI M
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J7639 is the Level II code for Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $56.806 per billing unit, up 0.1% from July 2026. The practitioner MUE allows up to 3 units per date of service (MAI 3), so a full 3-unit day is $170.42 at the current limit. Under OPPS it carries status indicator M. J7639 is billed in units of 1 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 1 NDC to it, sold as Pulmozyme by Genentech, Inc. No current Billing and Coding Article lists J7639, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J7639 at $56.806 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $56.78 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J7639
QuarterPayment limitPerCoinsurance
October 2026$56.8061 MG20%
July 2026$56.781 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J7639. Report the NDC in the claim's drug segment and bill the number of J7639 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J7639
NDCDrug nameLabelerPackage sizeBilling units / package
50242-0100-40PulmozymeGenentech, Inc.2.5 × 3075

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J7639. For practitioners the limit is 3 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J7639 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services33 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital03 Date of Service Edit: ClinicalCMS Policy
DME supplier2343 Date of Service Edit: ClinicalPublished Contractor Policy

MUE for J7639 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

Medicaid NCCI differs: the 2026 Q4 Medicaid MUE for J7639 is 3 units for outpatient hospital claims (Medicare: 0) and 78 units for DME supplier claims (Medicare: 234). Compare both programs in the MUE lookup or read how Medicaid NCCI differs from Medicare.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J7639 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J7639 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J7639 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J7639 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Local coverage policies that list J7639

1 active Local Coverage Determination lists J7639 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J7639 carries status indicator M. The OPPS status indicator reference explains how status M is paid.

Common denials for J7639 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J7639

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J7639

What does HCPCS code J7639 describe?

J7639 is defined by CMS as "Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J7639 a CPT code?

No. J7639 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as dornase alfa (Pulmozyme); CPT codes are five-character codes maintained by the AMA. On a Part B claim J7639 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J7639 in October 2026?

The ASP-based payment limit is $56.806 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $56.78. Commercial payers use their own fee schedules.

How many units of J7639 can be billed per day?

The practitioner Medically Unlikely Edit is 3 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 0. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J7639?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Pulmozyme (Genentech, Inc.). For example NDC 50242-0100-40 (package size 2.5) equals 75 billing units of J7639.

Does J7639 have NCCI bundling edits?

No active practitioner PTP pairs list J7639 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.